Aims: We assessed the interplay between hyperkalaemia (HK) and renin–angiotensin–aldosterone system inhibitor (RAASi) use, dose and discontinuation, and their association with all-cause or cardiovascular death in patients with chronic heart failure (HF). We hypothesized that HK-associated increased death may be related to RAASi withdrawal. Methods and results: The ESC-HFA-EORP Heart Failure Long-Term Registry was used. Among 9222 outpatients (HF with reduced ejection fraction: 60.6%, HF with mid-range ejection fraction: 22.9%, HF with preserved ejection fraction: 16.5%) from 31 countries, 16.6% had HK (≥5.0 mmol/L) at baseline. Angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB) was used in 88.3%, a mineralocorticoid receptor antagonist (MRA) in 58.7%, or a combination in 53.2%; of these, at ≥50% of target dose in ACEi: 61.8%; ARB: 64.7%; and MRA: 90.3%. At a median follow-up of 12.2 months, there were 789 deaths (8.6%). Both hypokalaemia and HK were independently. associated with higher mortality, and ACEi/ARB prescription at baseline with lower mortality. MRA prescription was not retained in the model. In multivariable analyses, HK at baseline was independently associated with MRA non-prescription at baseline and subsequent discontinuation. When considering subsequent discontinuation of RAASi (instead of baseline use), HK was no longer found associated with all-cause deaths. Importantly, all RAASi (ACEi, ARB, or MRA) discontinuations were strongly associated with mortality. Conclusions: In HF, hyper- and hypokalaemia were associated with mortality. However, when adjusting for RAASi discontinuation, HK was no longer associated with mortality, suggesting that HK may be a risk marker for RAASi discontinuation rather than a risk factor for worse outcomes.

Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry / P. Rossignol, M. Lainscak, M.G. Crespo-Leiro, C. Laroche, M.F. Piepoli, G. Filippatos, G.M.C. Rosano, G. Savarese, S.D. Anker, P.M. Seferovic, F. Ruschitzka, A.J.S. Coats, A. Mebazaa, T. McDonagh, A. Sahuquillo, M. Penco, A.P. Maggioni, L.H. Lund, G.B. Christopher Peter Gale, R.S. Branko Beleslin, P.L. Andrzej Budaj, R.O. Ovidiu Chioncel, D.E. Nikolaos Dagres, F.R. Nicolas Danchin, S.E. David Erlinge, G.B. Jonathan Emberson, I.L. Michael Glikson, G.B. Alastair Gray, T.R. Meral Kayikcioglu, I.T. Aldo Maggioni, H.U. Klaudia Vivien Nagy, R.U. Aleksandr Nedoshivin, I.T. Anna-Sonia Petronio, N.L. Jolien Roos-Hesselink, S.E. Lars Wallentin, D.E. Uwe Zeymer, S. Anker, A. Mebazaa, A. Coats, G. Filippatos, R. Ferrari, A.P. Maggioni, A. Goda, M. Diez, A. Fernandez, F. Fruhwald, E. Fazlibegovic, P. Gatzov, A. Kurlianskaya, R. Hullin, T. Christodoulides, J. Hradec, O.W. Nielsen, R. Nedjar, T. Uuetoa, M. Hassanein, J.F.D. Jimenez, V.P. Harjola, D. Logeart, V. Chumburidze, D. Tousoulis, D. Milicic, B. Merkely, E. O'Donoghue, O. Amir, A. Shotan, D. Shafie, M. Metra, A. Matsumori, E. Mirrakhimov, A. Kavoliuniene, A. Erglis, E. Vataman, M. Otljanska, E.S. Kostovska, D.C. DeMarco, J. Drozdz, C. Fonseca, O. Chioncel, M. Dekleva, E. Shkolnik, U. Dahlstrom, M. Lainscak, E. Goncalvesova, A. Temizhan, V. Estrago, G. Bajraktari, J. Auer, K. Ablasser, F. Fruhwald, T. Dolze, K. Brandner, S. Gstrein, G. Poelzl, D. Moertl, S. Reiter, A. Podczeck-Schweighofer, A. Muslibegovic, M. Vasilj, E. Fazlibegovic, M. Cesko, D. Zelenika, B. Palic, D. Pravdic, D. Cuk, K. Vitlianova, T. Katova, T. Velikov, T. Kurteva, P. Gatzov, D. Kamenova, M. Antova, V. Sirakova, J. Krejci, M. Mikolaskova, J. Spinar, J. Krupicka, F. Malek, M. Hegarova, M. Lazarova, Z. Monhart, M. Hassanein, M. Sobhy, F. El Messiry, A.H. El Shazly, Y. Elrakshy, A. Youssef, A.A. Moneim, M. Noamany, A. Reda, T.K.A. Dayem, N. Farag, S.I. Halawa, M.A. Hamid, K. Said, A. Saleh, H. Ebeid, R. Hanna, R. Aziz, O. Louis, M.A. Enen, B.S. Ibrahim, G. Nasr, A. Elbahry, H. Sobhy, M. Ashmawy, M. Gouda, W. Aboleineen, Y. Bernard, P. Luporsi, N. Meneveau, M. Pillot, M. Morel, M.-. Seronde, F. Schiele, F. Briand, F. Delahaye, T. Damy, J.-. Eicher, P. de Groote, M. Fertin, N. Lamblin, R. Isnard, C. Lefol, S. Thevenin, A. Hagege, G. Jondeau, D. Logeart, V. Le Marcis, J.-. Ly, D. Coisne, B. Lequeux, V. Le Moal, S. Mascle, P. Lotton, N. Behar, E. Donal, C. Thebault, C. Ridard, A. Reynaud, A. Basquin, F. Bauer, R. Codjia, M. Galinier, P. Tourikis, M. Stavroula, D. Tousoulis, C. Stefanadis, C. Chrysohoou, I. Kotrogiannis, V. Matzaraki, T. Dimitroula, A. Karavidas, G. Tsitsinakis, C. Kapelios, J. Nanas, H. Kampouri, E. Nana, E. Kaldara, A. Eugenidou, P. Vardas, I. Saloustros, A. Patrianakos, T. Tsaknakis, S. Evangelou, N. Nikoloulis, H. Tziourganou, A. Tsaroucha, A. Papadopoulou, A. Douras, L. Polgar, A. Kosztin, N. Nyolczas, A.C. Nagy, R. Halmosi, J. Elber, I. Alony, A. Shotan, A.V. Fuhrmann, O. Amir, S. Romano, S. Marcon, M. Penco, M. Di Mauro, E. Lemme, V. Carubelli, R. Rovetta, M. Bulgari, F. Quinzani, C. Lombardi, S. Bosi, G. Schiavina, A. Squeri, A. Barbieri, G. Di Tano, S. Pirelli, R. Ferrari, A. Fucili, T. Passero, S. Musio, M. Di Biase, M. Correale, G. Salvemini, S. Brognoli, E. Zanelli, A. Giordano, P. Agostoni, G. Italiano, E. Salvioni, S. Copelli, M.G. Modena, L. Reggianini, C. Valenti, A. Olaru, S. Bandino, M. Deidda, G. Mercuro, C.C. Dessalvi, P.N. Marino, M.V. Di Ruocco, C. Sartori, C. Piccinino, G. Parrinello, G. Licata, D. Torres, S. Giambanco, S. Busalacchi, S. Arrotti, S. Novo, R.M. Inciardi, P. Pieri, P.R. Chirco, M.A. Galifi, G. Teresi, D. Buccheri, A. Minacapelli, M. Veniani, A. Frisinghelli, S.G. Priori, S. Cattaneo, C. Opasich, A. Gualco, M. Pagliaro, M. Mancone, F. Fedele, A. Cinque, M. Vellini, I. Scarfo, F. Romeo, F. Ferraiuolo, D. Sergi, M. Anselmi, F. Melandri, E. Leci, E. Iori, V. Bovolo, S. Pidello, S. Frea, S. Bergerone, M. Botta, F.G. Canavosio, F. Gaita, M. Merlo, M. Cinquetti, G. Sinagra, F. Ramani, E. Fabris, D. Stolfo, J. Artico, D. Miani, C. Fresco, C. Daneluzzi, A. Proclemer, M. Cicoira, L. Zanolla, G. Marchese, F. Torelli, C. Vassanelli, N. Voronina, V. Tamakauskas, V. Smalinskas, R. Karaliute, I. Petraskiene, E. Kazakauskaite, E. Rumbinaite, A. Kavoliuniene, V. Vysniauskas, R. Brazyte-Ramanauskiene, D. Petraskiene, S. Stankala, P. Switala, Z. Juszczyk, W. Sinkiewicz, W. Gilewski, J. Pietrzak, T. Orzel, P. Kasztelowicz, P. Kardaszewicz, M. Lazorko-Piega, J. Gabryel, K. Mosakowska, J. Bellwon, A. Rynkiewicz, G. Raczak, E. Lewicka, A. Dabrowska-Kugacka, R. Bartkowiak, B. Sosnowska-Pasiarska, B. Wozakowska-Kaplon, A. Krzeminski, M. Zabojszcz, E. Mirek-Bryniarska, A. Grzegorzko, K. Bury, J. Nessler, J. Zalewski, A. Furman, M. Broncel, A. Poliwczak, A. Bala, P. Zycinski, M. Rudzinska, L. Jankowski, J.D. Kasprzak, L. Michalak, K.W. Soska, J. Drozdz, I. Huziuk, A. Retwinski, P. Flis, J. Weglarz, A. Bodys, S. Grajek, M. Kaluzna-Oleksy, E. Straburzynska-Migaj, R. Dankowski, K. Szymanowska, J. Grabia, A. Szyszka, A. Nowicka, M. Samcik, L. Wolniewicz, K. Baczynska, K. Komorowska, I. Poprawa, E. Komorowska, D. Sajnaga, A. Zolbach, A. Dudzik-Plocica, A.-. Abdulkarim, A. Lauko-Rachocka, L. Kaminski, A. Kostka, A. Cichy, P. Ruszkowski, M. Splawski, G. Fitas, A. Szymczyk, A. Serwicka, A. Fiega, D. Zysko, W. Krysiak, S. Szabowski, E. Skorek, P. Pruszczyk, P. Bienias, M. Ciurzynski, M. Welnicki, A. Mamcarz, A. Folga, T. Zielinski, T. Rywik, P. Leszek, M. Sobieszczanska-Malek, M. Piotrowska, K. Kozar-Kaminska, K. Komuda, J. Wisniewska, A. Tarnowska, P. Balsam, M. Marchel, G. Opolski, A. Kaplon-Cieslicka, R.J. Gil, O. Mozenska, K. Byczkowska, K. Gil, A. Pawlak, A. Michalek, P. Krzesinski, K. Piotrowicz, B. Uzieblo-Zyczkowska, A. Stanczyk, A. Skrobowski, P. Ponikowski, E. Jankowska, P. Rozentryt, L. Polonski, E. Gadula-Gacek, E. Nowalany-Kozielska, A. Kuczaj, Z. Kalarus, M. Szulik, K. Przybylska, J. Klys, G. Prokop-Lewicka, A. Kleinrok, C.T. Aguiar, A. Ventosa, S. Pereira, R. Faria, J. Chin, I. De Jesus, R. Santos, P. Silva, N. Moreno, C. Queiros, C. Lourenco, A. Pereira, A. Castro, A. Andrade, T.O. Guimaraes, S. Martins, R. Placido, G. Lima, D. Brito, A.R. Francisco, R. Cardiga, M. Proenca, I. Araujo, F. Marques, C. Fonseca, B. Moura, S. Leite, M. Campelo, J. Silva-Cardoso, J. Rodrigues, I. Rangel, E. Martins, A.S. Correia, M. Peres, L. Marta, G.F. da Silva, D. Severino, D. Durao, S. Leao, P. Magalhaes, I. Moreira, A.F. Cordeiro, C. Ferreira, C. Araujo, A. Ferreira, A. Baptista, M. Radoi, G. Bicescu, D. Vinereanu, C.-. Sinescu, C. Macarie, R. Popescu, I. Daha, G.-. Dan, C. Stanescu, A. Dan, E. Craiu, E. Nechita, V. Aursulesei, R. Christodorescu, P. Otasevic, P.M. Seferovic, D. Simeunovic, A.D. Ristic, V. Celic, M. Pavlovic-Kleut, J.S. Lazic, B. Stojcevski, B. Pencic, A. Stevanovic, A. Andric, D. Simic, M. Asanin, V. Iric-Cupic, M. Jovic, G. Davidovic, S. Milanov, V. Mitic, V. Atanaskovic, S. Antic, M. Pavlovic, D. Stanojevic, V. Stoickov, S. Ilic, M.D. Ilic, D. Petrovic, S. Stojsic, S. Kecojevic, S. Dodic, N.C. Adic, M. Cankovic, J. Stojiljkovic, B. Mihajlovic, A. Radin, S. Radovanovic, M. Krotin, A. Klabnik, E. Goncalvesova, M. Pernicky, J. Murin, F. Kovar, J. Kmec, H. Semjanova, M. Strasek, M.S. Iskra, T. Ravnikar, N.C. Suligoj, J. Komel, Z. Fras, B. Jug, T. Glavic, R. Losic, M. Bombek, I. Krajnc, B. Krunic, S. Horvat, D. Kovac, D. Rajtman, V. Cencic, M. Letonja, R. Winkler, M. Valentincic, C. Melihen-Bartolic, A. Bartolic, M.P. Vrckovnik, M. Kladnik, C.S. Pusnik, A. Marolt, J. Klen, B. Drnovsek, B. Leskovar, M.J.F. Anguita, J.C.G. Page, F.M.S. Martinez, J. Andres, A. Bayes-Genis, S. Mirabet, A. Mendez, L. Garcia-Cosio, E. Roig, V. Leon, J. Gonzalez-Costello, G. Muntane, A. Garay, V. Alcade-Martinez, S.L. Fernandez, R. Rivera-Lopez, M. Puga-Martinez, M. Fernandez-Alvarez, J.L. Serrano-Martinez, Z. Grille-Cancela, R. Marzoa-Rivas, P. Blanco-Canosa, M.J. Paniagua-Martin, E. Barge-Caballero, I.L. Cerdena, I.F.H. Baldomero, A.L. Padron, S.O. Rosillo, R.D. Gonzalez-Gallarza, O.S. Montanes, A.M.I. Manjavacas, A.C. Conde, A. Araujo, T. Soria, P. Garcia-Pavia, M. Gomez-Bueno, M. Cobo-Marcos, L. Alonso-Pulpon, J.S. Cubero, I. Sayago, A. Gonzalez-Segovia, A. Briceno, P.E. Subias, M.V. Hernandez, M.J.R. Cano, M.A.G. Sanchez, J.F.D. Jimenez, E.B. Garrido-Lestache, J.M.G. Pinilla, B.G. de la Villa, A. Sahuquillo, R.B. Marques, F.T. Calvo, M.T. Perez-Martinez, M.R. Gracia-Rodenas, I.P. Garrido-Bravo, F. Pastor-Perez, D.A. Pascual-Figal, B.D. Molina, J. Orus, F.E. Gonzalo, V. Bertomeu, R. Valero, R. Martinez-Abellan, J. Quiles, J.A. Rodrigez-Ortega, I. Mateo, A. ElAmrani, C. Fernandez-Vivancos, D.B. Valero, L. Almenar-Bonet, I.J. Sanchez-Lazaro, E. Marques-Sule, L. Facila-Rubio, J. Perez-Silvestre, P. Garcia-Gonzalez, F. Ridocci-Soriano, D. Garcia-Escriva, A. Pellicer-Cabo, L. de la Fuente Galan, J.L. Diaz, A.R. Platero, J.C. Arias, T. Blasco-Peiro, M.S. Julve, E. Sanchez-Insa, C. Aured-Guallar, A. Portoles-Ocampo, M. Melin, E. Hagglund, A. Stenberg, I.-. Lindahl, B. Asserlund, L. Olsson, U. Dahlstrom, M. Afzelius, P. Karlstrom, L. Tengvall, B. Olsson, S. Kalayci, A. Temizhan, Y. Cavusoglu, E. Gencer, M.B. Yilmaz, H. Gunes. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - 22:8(2020 Aug), pp. 1378-1389. [10.1002/ejhf.1793]

Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

P. Agostoni
Membro del Collaboration Group
;
2020

Abstract

Aims: We assessed the interplay between hyperkalaemia (HK) and renin–angiotensin–aldosterone system inhibitor (RAASi) use, dose and discontinuation, and their association with all-cause or cardiovascular death in patients with chronic heart failure (HF). We hypothesized that HK-associated increased death may be related to RAASi withdrawal. Methods and results: The ESC-HFA-EORP Heart Failure Long-Term Registry was used. Among 9222 outpatients (HF with reduced ejection fraction: 60.6%, HF with mid-range ejection fraction: 22.9%, HF with preserved ejection fraction: 16.5%) from 31 countries, 16.6% had HK (≥5.0 mmol/L) at baseline. Angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB) was used in 88.3%, a mineralocorticoid receptor antagonist (MRA) in 58.7%, or a combination in 53.2%; of these, at ≥50% of target dose in ACEi: 61.8%; ARB: 64.7%; and MRA: 90.3%. At a median follow-up of 12.2 months, there were 789 deaths (8.6%). Both hypokalaemia and HK were independently. associated with higher mortality, and ACEi/ARB prescription at baseline with lower mortality. MRA prescription was not retained in the model. In multivariable analyses, HK at baseline was independently associated with MRA non-prescription at baseline and subsequent discontinuation. When considering subsequent discontinuation of RAASi (instead of baseline use), HK was no longer found associated with all-cause deaths. Importantly, all RAASi (ACEi, ARB, or MRA) discontinuations were strongly associated with mortality. Conclusions: In HF, hyper- and hypokalaemia were associated with mortality. However, when adjusting for RAASi discontinuation, HK was no longer associated with mortality, suggesting that HK may be a risk marker for RAASi discontinuation rather than a risk factor for worse outcomes.
Heart failure; Hyperkalaemia; Hypokalaemia; Mineralocorticoid receptor antagonists; Prognosis; Renin–angiotensin–aldosterone system inhibitors; Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Humans; Mineralocorticoid Receptor Antagonists; Registries; Renin; Heart Failure; Hyperkalemia
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
ago-2020
3-apr-2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
European J of Heart Fail - 2020 - Rossignol - Unravelling the interplay between hyperkalaemia renin angiotensin.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 6.12 MB
Formato Adobe PDF
6.12 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/898114
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 109
  • ???jsp.display-item.citation.isi??? 103
social impact